BD and Return Safe collaborate on COVID-19 testing solution

Feb. 8, 2022

BD (Becton, Dickinson, and Company) is collaborating with ReturnSafe to integrate the BD Veritor At-Home COVID-19 Test directly within the ReturnSafe testing management platform.

"The BD Veritor At-Home COVID-19 Test enables people to test from home, without a proctor, while ensuring verifiable results because test results can only be read using a smartphone," said Dave Hickey, President of Life Sciences for BD. "The test eliminates human subjectivity in reading the result because there is no guessing game about one line or two, as is sometimes the case with visually read tests. You get a definitive 'POSITIVE' or 'NEGATIVE' digital display that is dated and time-stamped in the app and reporting of the results to a business or organization can also be fully automated.”

The BD Veritor At-Home COVID-19 Test displays results in 15 minutes.

By using the BD Veritor At-Home COVID-19 Test with ReturnSafe, employers can collect test results, track who has completed testing requirements on time, quickly identify positive cases to act, manage isolation and quarantine workflows, as well as collect data for compliance reporting, BD said. The test also automates the reporting of results to federal and state public health agencies.

The BD Veritor At-Home COVID-19 Test has been authorized by U.S. Food and Drug Administration (FDA) under emergency use authorization (EUA).

Visit BD for more news

More on COVID